E-drug: Therapeutics Letter 42 now on the web
-------------------------------------------------------------------------
I would like to bring to your attention the August/September/
October 2001 issue (#42) of the Therapeutics Letter: "Serious
Adverse Event Analysis: Lipid-Lowering Therapy Revisited" that is
now available on the Therapeutics Initiative web-site at
http://www.ti.ubc.ca/pages/letter42.htm
I invite you to drop by and have a look at this Letter. Please feel
free to forward this message to any of your friends or colleagues
that might be interested in this topic.
We would appreciate receiving your comments on this Therapeutics
Letter and its possible implications in clinical practice.
Best regards,
Ciprian D Jauca
Program Coordinator
Therapeutics Initiative - Evidence Based Drug Therapy
University of British Columbia
Vancouver, BC, Canada
Phone: +1 (604) 822-0700
GSM mobile phone: +1 (604) 722-2075
Fax: +1 (604) 822-0701
Email: jauca@ti.ubc.ca
Web site: www.ti.ubc.ca
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Information and archive http://satellife.healthnet.org/programs/edrug.html
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.